PetBioCell is a family run business and has developed out of the veterinary hospital from Dr. Thomas Grammel in Osterode, Germany, into a specialized GMP laboratory for dendritic cell therapies. Focusing on the quality of life of dogs, cats and horses, PetBioCell produces individualized dendritic cell therapies for cancer treatments in solid tumors in these animals.

We are pleased to announce that PetBioCell has qualified for presentation at the Innovation Showcase at the Animal Health Investment Forum Europe.